Retatrutide – 36 MG

Retatrutide – 36MG is a triple hormone receptor agonist, selectively activating GLP-1, GIP, and glucagon receptors. This compound has gained significant attention for its powerful effects on weight loss, insulin sensitivity, fat oxidation, and overall metabolic function.

This mid-high dose 36MG format offers an ideal balance for 4–6 week research studies, perfect for advanced metabolic modelling or extended research timelines without committing to bulk quantities like 50MG or 60MG vials.

Key Research Highlights:

• Triple Action Synergy:
  GLP-1 (appetite suppression), GIP (insulin enhancement), and glucagon (fat mobilisation) in one compound

• Clinical-Grade Performance:
  Demonstrated up to 24%+ body weight reduction in human trials—surpassing results of Semaglutide and Tirzepatide

• Metabolic Enhancement:
  Improves glucose control, liver fat reduction, and energy expenditure

• Advanced Satiety Regulation:
  Acts on the brain’s hunger centres to reduce cravings and calorie intake

Reconstitution & Storage Guidelines:

• Reconstitute with 2–3ml of Bacteriostatic Water for Injection (BWFI)

• Swirl gently until fully dissolved – do not shake

• Store reconstituted solution at 2–8°C

• Use within 30 days of reconstitution

Why Choose the 36MG Format?

• Balanced quantity for 1-month+ research protocols

• Ideal for mid-term dose escalation studies

• 99% purity with full lab COA provided

• Manufactured under strict GMP and ISO quality standards

⚠️ Notice: This product is intended strictly for scientific, laboratory, and research use only. Not for human consumption, therapeutic use, or veterinary application.